Clinical Research Directory

CGM After Discharge From Hospital

Sponsor: Icahn School of Medicine at Mount Sinai

Summary

This is an investigator initiated prospective, randomized controlled trial which aims to compare two groups of patients with either type 2 or steroid-induced diabetes who are discharged with insulin. The intervention group will use the Libre 3 Plus continuous glucose monitoring (CGM) system at discharge, while the control group will use blinded CGM and fingerstick monitoring. Both the intervention and control groups will wear the sensor for 28 days post discharge and participate in telehealth diabetes management visits. The target enrollment for the study is 65 participants and participants are expected to be in the study for up to 35 days.

Official title: Continuous Glucose Monitoring for Post-discharge Diabetes Management

Key Details

Conditions

Interventions

Locations (1)